Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took one capsule and left the product out of the fridge; no more capsules were taken.; Case reference number US-BN-2025-001708 is a spontaneous case initially received from a pharmacy technician via Bavarian Nordic Safety (reference number: CASE-000389) on 21-Oct-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 08-Oct-2025, the patient took a dose of Vivotif (batch number: unknown, expiration date: unknown), at an unknown dose, route or site of administration for an unknown indication. On unspecified date, for an unspecified amount of time, after taking the dose of Vivotif (batch number: unknown, expiration date: unknown) the patient left the product out of the fridge but did not take any more capsules (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it was unknown whether the patient experienced any adverse event due to Vivotif. No further information's were provided; Reporter's Comments: A female patient of unspecified age did not take any more capsules after taking the dose of Vivotif for an unknown indication, which is considered as incomplete course of vaccination. It was unknown whether the patient experienced any adverse event due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medications details were provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age did not take any more capsules after taking the dose of Vivotif for an unknown indication, which is considered as incomplete course of vaccination. It was unknown whether the patient experienced any adverse event due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medications details were provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE.